New approaches for the treatment of colorectal cancer in the adjuvant setting
The value of adjuvant chemotherapy for some patients with stage III colorectal cancer has been established but the situation is less clear for stage II disease. Currently, infusional or bolus 5-fluorouracil (5-FU)/folinic acid (FA) is the treatment of choice but its success is limited and the use of...
Main Authors: | Kerr, D, Van Cutsem, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
COX-2 INHIBITION IN THE ADJUVANT SETTING FOR COLORECTAL CANCER
by: Kerr, D
Published: (2010) -
Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
by: Kerr, D, et al.
Published: (2000) -
Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
by: Kerr, D, et al.
Published: (2000) -
What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
by: Johnstone, E, et al.
Published: (2008) -
Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors
by: Cascinu, S, et al.
Published: (2003)